Search Results
Dr. Edith Perez on Immune Checkpoint Inhibition in Triple-Negative Breast Cancer
Dr. Perez on Immune Checkpoint Inhibition in Breast Cancer
Dr. Edith Perez on the Etirinotecan Pegol for HER2-Negative Breast Cancer
Checkpoint inhibitors for triple-negative breast cancer
Dr. Edith Perez Discusses BOLERO-1 Trial Results for HER2-Positive Breast Cancer
TNT Study in Triple Negative Breast Cancer
Dr. Edith Perez on Adjuvant Treatments
Dr. Edith Perez on the Antibody-Drug Conjugate T-DM1
Breast cancer: maximizing response to checkpoint inhibitors
Dr. Edith Perez on the development of targeted therapies
Dr. Edith Perez Describes the Mayo Clinic Breast Cancer Translational Genomics Program
Dr. Perez on T-DM1 and the MARIANNE Trial